R Squared’s Aura Biosciences AURA Stock Holding History

R Squared’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-480	Closed	-$3.95K	–	399
2024 Q4	$3.95K	Buy	+480	New	+$4.52K	﹤0.01%	1364

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

R Squared's AURA Position: Q1 2025 in Review

R Squared sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 480 shares — an estimated $3.95K sold.

R Squared first reported a position in AURA in Q4 2024 and held it in 1 quarter. The position peaked at $3.95K in Q4 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

R Squared reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
R Squared sold 480 Aura Biosciences shares in Q1 2025, an estimated $3.95K.
R Squared first reported a position in Aura Biosciences in Q4 2024 and held it in 1 quarter.
R Squared's Aura Biosciences position peaked at $3.95K in Q4 2024.
94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.